long-acting HIV treatment Stories

Lenacapavir, long-acting injectables show strong potential in HIV treatment
Lenacapavir, long-acting injectables show strong potential in HIV treatment
Charity Kilei  |  Dec 03, 2025

New data from African trials and global studies show long-acting HIV injections can match daily pills for viral suppression and prevention, with fewer...

MoH flags surge in youth HIV infections, calls for stronger prevention strategies
MoH flags surge in youth HIV infections, calls for stronger prevention strategies
Rachael Mutabasi  |  Jun 18, 2025

Medical Services Principal Secretary Dr Ouma Oluga says nearly 6,000 new infections had been recorded among individuals aged 15 to 24.

US aid cuts threaten youth development gains globally, study warns
US aid cuts threaten youth development gains globally, study warns
Alfred Onyango  |  Apr 18, 2025

The impact goes beyond healthcare, with experts now warning that the cuts will significantly affect youth development, a critical yet often overlooked...

Kenya's HIV milestone: Transition to DTG and strides in treatment
Kenya's HIV milestone: Transition to DTG and strides in treatment
Charity Kilei  |  Jan 17, 2025

HIV prevention drug expected to be launched in Kenya next year
HIV prevention drug expected to be launched in Kenya next year
Maureen Kinyanjui  |  Oct 05, 2024

The drug, lenacapavir, is administered via an injection twice a year.

Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.